The remaining unresolved cases (10 cases with non-BRAF/non RELA/ZFTA fusions and 16 non-WNT/non-SHH medulloblastoma) can then be subjected to NanoString, NGS, or other advanced molecular testing methods. This evidence concerns the gene BRAF and medulloblastoma.